3.96
Kezar Life Sciences Inc Azioni (KZR) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
|
18.24%
17.63
|
21.56 | 21.95 | 23.38 | 23.71 |
Operating Income/Loss |
18.24%
-17.63
|
-21.56 | -21.95 | -23.38 | -23.71 |
Income/Loss From Continuing Operations Before Tax |
18.11%
-16.56
|
-20.22 | -20.31 | -21.55 | -21.66 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
18.11%
-16.56
|
-20.22 | -20.31 | -21.55 | -21.66 |
|
18.11%
-16.56
|
-20.22 | -20.31 | -21.55 | -21.66 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
222.77K%
7.3057
|
0.00328 | 7.2962 | 72.85 | 72.80 |
Diluted Average Shares |
222.77K%
7.3057
|
0.00328 | 7.2962 | 72.85 | 72.80 |
Basic Earnings Per Share |
18.05%
-2.27
|
-2.77 | -2.78 | -0.30 | -0.30 |
Diluted Earnings Per Share |
18.05%
-2.27
|
-2.77 | -2.78 | -0.30 | -0.30 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):